Understanding the Medicines
What Is Psychedelic-Assisted Therapy?
For thousands of years, indigenous cultures have used psychedelic plants as medicine. Not recreationally, but as carefully held tools for healing and ceremony. Western science largely ignored this until the 1950s, when researchers began pairing compounds like LSD with psychotherapy, discovering that music, intention, and a trusted therapeutic relationship transformed what was possible.
What makes psychedelic-assisted therapy different from conventional treatment isn’t just the substance. It’s the direction of travel. Psychedelics turn up the volume on the inner world, bringing emotions, memories, and patterns that have been quietly running in the background into the foreground where they can actually be met. Research suggests they put the brain into a more flexible, open state, a window where things that have felt stuck for years can finally begin to move.
A typical process unfolds in three phases: preparation, where trust is built and intentions are clarified; the experience itself, held in a safe container with a guide present throughout; and integration, often the most underestimated phase, where insights are woven into everyday life. Without integration, even powerful experiences can fade. With it, they tend to stick.
The science is catching up. Nearly 300 clinical trials for psychedelic compounds have been registered globally. Psilocybin has shown sustained remission in over half of treatment-resistant depression patients at six months. MDMA-assisted therapy demonstrated meaningful PTSD reduction in a randomized Phase 2 trial published in The Lancet Psychiatry, specifically among veterans, firefighters, and police officers, with effects lasting through 12 months. Phase 3 trials published in Nature Medicine have included survivors of sexual assault and complex childhood trauma, with participants reporting reduced PTSD symptoms and a greater sense of self-compassion and agency.
The science is still evolving, and not every experience produces dramatic results. But for people who have tried conventional treatment without lasting relief, the research suggests these medicines are worth understanding.
A Note on Trauma and PTSD
Research into psychedelic-assisted therapy is producing some of its most meaningful results in the area of trauma. The findings are particularly significant for people whose experiences have been shaped by military service, first responder work, sexual assault, adverse childhood experiences, and the ongoing weight of systemic racism, homophobia, transphobia, and the particular stresses of immigration.
For people carrying complex PTSD, these medicines, held within a safe and skilled container, are opening doors that have long felt sealed. The science is still growing, but what it is pointing toward is genuinely hopeful.
Psilocybin
Psilocybin is a naturally occurring compound found in certain species of mushrooms, used ceremonially by Indigenous cultures for thousands of years and now one of the most actively researched substances in modern psychiatry.
MDMA
Of all the medicines currently being studied for mental health, MDMA may be the most surprising. It doesn’t produce the visual experiences or perceptual shifts people associate with psychedelics. What it does instead is quieter and in many ways more profound.
Ketamine
Ketamine occupies a unique position in the landscape of psychedelic medicine. It is the only medicine on this page that is currently legal for therapeutic use in the United States. If you’ve been curious but felt uncertain about accessing it, ketamine may be the most accessible starting point.
The information on this page reflects current research in psychedelic medicine and is offered purely for educational purposes, not as medical or psychiatric advice. I am not a licensed therapist or healthcare provider, and nothing here should replace professional medical care.
If you’re curious about what preparation, journey support, or integration might look like for you, I’d love to hear from you.